Mirabaud Asset Management’s AbbVie ABBV Stock Holding History

Mirabaud Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.34M	Buy	25,045 +9,636	+63%	+$2.14M	4.4%	11
2025 Q4	$2.96M	Buy	15,409 +5,131	+50%	+$1.17M	1.37%	25
2025 Q3	$2.29M	Sell	10,278 -1,054	-9%	-$215K	1.11%	25
2025 Q2	$2.07M	Sell	11,332 -668	-6%	-$124K	0.96%	27
2025 Q1	$2.46M	Sell	12,000 -4,801	-29%	-$933K	1.29%	26
2024 Q4	$2.96M	Hold	16,801	–	–	1.38%	23
2024 Q3	$3.27M	Buy	16,801 +7,726	+85%	+$1.44M	1.35%	28
2024 Q2	$1.56M	Sell	9,075 -110	-1%	-$18.2K	0.72%	34
2024 Q1	$1.67M	Buy	+9,185	New	+$1.58M	0.68%	32

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mirabaud Asset Management's ABBV Position: Q1 2026 in Review

Mirabaud Asset Management increased its AbbVie (ABBV) stake by 63% in Q1 2026, buying an estimated $2.14M and bringing the position to 25,045 shares worth $5.34M. The position accounts for 4.4% of the portfolio, ranked #11.

Mirabaud Asset Management first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Mirabaud Asset Management held 25,045 shares of AbbVie worth $5.34M as of Q1 2026.
Mirabaud Asset Management bought 9,636 AbbVie shares in Q1 2026, an estimated $2.14M.
AbbVie made up 4.4% of Mirabaud Asset Management's portfolio in Q1 2026, its #11 holding.
Mirabaud Asset Management first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Mirabaud Asset Management's 13F filing for Q1 2026, filed 13 May 2026.